Welcome to Psoriasis Guide
Psoriasis Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
The Causes, Symptoms and Treatments for Plaque Psoriasis
from:The occurrence of plaque psoriasis is not a rare thing. In fact, plaque psoriasis is the most common type of psoriasis around, and psoriasis is said to infect at least 2% of the present population in the US. Plaque psoriasis is a disease that manifests itself on certain parts of a person's anatomy, and usually these manifestations come in the form of red, scaly blotches that are either itchy or pretty unsightly to look at. How does one get plaque psoriasis and what can be done to help a person get over the symptoms of this disease?
The disease known as plaque psoriasis is usually acquired through heredity, although there are also indications that the disease can develop in people that are HIV positive, smokers or drug users. There are also indications that plaque psoriasis can occur in people who are stressed out, alcohol drinkers, or those who are exposed to too much sunlight. While these factors may indeed trigger the emergence of psoriasis, the usual reason for a person having psoriasis is due to the fact that his or her parents have it. The possibility of a child developing psoriasis rises if both parents have the disease and it diminishes slightly when only one parent has the skin problem.
Plaque psoriasis often manifests itself first as a reddish rash or burn that may or may not itch. These very red patches of skin may eventually develop a scaly scab that when peeled off will reveal a reddish skin that may bleed or crack. The scales and plaques that this kind of psoriasis causes may appear anywhere on a person's body, and it may cause discomfort, pain or even infection if it is not taken care of. These flare-ups usually last around a few weeks to as long as a few months, and they may recur after a few months of living without any flare-ups.
Treatments for plaque psoriasis vary according to the severity of the affliction, and they are available in either combination treatments or solo treatments. There are topical medications, oral or systemic treatments, and photo therapy treatments that can help with the flare-ups that a psoriasis sufferer experiences. These can be administered in conjunction with one another, depending on how severe a psoriasis case may be. The topical medications can also be purchased as over the counter medications, or as prescription creams and ointments, depending on what the attending physician advises the patient to do. Systemic treatments can come in either oral or injection forms while photo therapy usually uses either UV rays or laser to help get rid of the flare-ups on a person’s skin.
Psoriasis News
Philippines' National Psoriasis And Psoriatic Arthritis Conference - October 28 2008 (Medical News Today)
The NPPAC-2008 recognizes the many diverse and emerging issues involved with psoriasis raised by the Filipinos with Psoriasis around the Philippines.
Read more...Overcoming the scaly skin stigma (The Borneo Post)
PEOPLE do not recoil in horror at the sight of wrinkles but psoriasis, an unsightly skin condition, can cause them to point, stare in disgust and look the other way as well as avoid coming into contact with an afflicted person for fear of catching the condition.
Read more...LSUHSC awarded patent for compound inhibiting cancer and other diseases (EurekAlert!)
( Louisiana State University Health Science Center ) Dr. Eugene Woltering, the James D. Rives Professor of Surgery and Neurosciences at LSU Health Sciences Center New Orleans School of Medicine, and Dr. Conrad Hornick, former LSUHSC professor of physiology, have been awarded a US patent for a compound to inhibit the formation of blood vessels critical to the growth of cancerous tumors and ...
Read more...PanGenetics To Initiate Clinical Study Of CD40 Antagonist Antibody In Psoriatic Arthritis (Medical News Today)
PanGenetics B.V. announced today that the company has received formal regulatory approval to initiate clinical evaluation of the company's CD40 antagonist antibody, PG102. The multi-centre trial in Hungary and Serbia will recruit patients with active psoriatic arthritis, and is designed as a double blind, placebo controlled, single ascending dose study.
Read more...Genentech Issues Dear Healthcare Provider Letter Regarding A Reported Case Of PML In A Raptiva Patient (Medical News Today)
Genentech, Inc. (NYSE: DNA) announced that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had received Raptiva® (efalizumab) for more than four years for treatment of chronic plaque psoriasis. The company will work with the U.S.
Read more...(AFX UK Focus) 2008-10-06 13:34 UPDATE 1-Remicade tops azathioprine in Crohn's disease study (Interactive Investor)
NEW YORK NEW YORK, Oct 6 (Reuters) - Crohn's disease patients taking Johnson & Johnson's Remicade either alone or with azathioprine experienced steroid-free remission in significantly greater numbers than those taking azathioprine alone, according to results of a clinical trial. Patients who received Remicade in the study also had greater mucosal healing -- the healing of ulcers in the bowel ...
Read more...